GlucoTrack (GCTK) vs Nuwellis (NUWE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Nuwellis is the larger company by market cap ($2.5 million vs $1.1 million), about 2.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GCTK | NUWE |
|---|---|---|
| Share price | $1.11 | $0.6751 |
| Market cap | $1.13M | $2.46M |
| 1-day change | -3.48% | -1.92% |
| P/E ratio (TTM) | — | 0.00 |
| EPS (TTM) | $-123.15 | $435.92 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $125.25 | $172.90 |
| 52-week low | $1.07 | $0.6709 |
| Distance from 52-week high | -99.11% | -99.61% |
| Average volume | 2.06M | 4.33M |
| Shares outstanding | 1.02M | 3.65M |
| Employees | 15 | 38 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Nuwellis is about 2.2 times larger than GlucoTrack by market value ($2.46M vs $1.13M).
About GlucoTrack
GCTK stock →GlucoTrack, Inc., a medical device company, focuses on the development of an implantable continuous blood glucose monitor (CBGM) for people with diabetes in the United States. The company develops the GlucoTrack CBGM, a long-term implantable blood-based CBGM for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
Healthcare · Medical Devices · 15 employees
About Nuwellis
NUWE stock →Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
Healthcare · Medical Devices · 38 employees
GCTK vs NUWE FAQ
Which is bigger, GlucoTrack or Nuwellis?
Nuwellis (NUWE) is larger, with a market capitalization of $2.46M compared with $1.13M for GlucoTrack (GCTK).
Are GlucoTrack and Nuwellis in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.